SEC Form 4 · accession 0001437749-26-023637
BioCardia, Inc. · BCDA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Peter Altman
Officer — President and CEO · Director
Period of report
Jul 14, 2026
Accepted (ET)
Jul 15, 2026 · 4:40 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0000925741
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jul 14, 2026 | P | 2,800 | $0.88 | A | 366,885 | D | |
| Common StockF2 | Jul 15, 2026 | P | 1,500 | $0.86 | A | 368,385 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This transaction was executed in multiple trades ranging from $0.86 to $0.89 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number shares purchased at each separate price.
- F2This transaction was executed in multiple trades ranging from $0.86 to $0.89 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number shares purchased at each separate price.